Xeris Biopharma Holdings (XERS) Inventory (2020 - 2026)
Xeris Biopharma Holdings' (XERS) quarterly Inventory came in at $74.2 million in Q1 2026, up 40.89% YoY from $52.7 million in Q1 2025, and up 8.1% on a QoQ basis from $68.7 million in Q4 2025.
Xeris Biopharma Holdings (XERS) Inventory (2020 - 2026) Analysis & Trends
Xeris Biopharma Holdings (XERS) has 7 years of Inventory data on file, last reported at $74.2 million in Q1 2026.
- Quarterly Inventory rose 40.89% year-over-year to $74.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $74.2 million (up 40.89% YoY) and the FY2025 annual result came in at $68.7 million, up 42.55% from the prior year.
- Inventory climbed to $74.2 million in Q1 2026, from $68.7 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $74.2 million in Q1 2026 to a low of $16.9 million in Q1 2022.
- A 5-year average of $42.9 million and a median of $40.9 million in 2024 frame the typical range for Inventory.
- Annual changes were most pronounced in 2023 — Inventory soared 104.27% — and 2024, when it increased 17.62%.
- Tracing XERS's Inventory over 5 years: stood at $24.7 million in 2022, then soared by 57.02% to $38.8 million in 2023, then rose by 24.04% to $48.2 million in 2024, then soared by 42.55% to $68.7 million in 2025, then rose by 8.1% to $74.2 million in 2026.
- The last three Inventory figures came in at $74.2 million (Q1 2026), $68.7 million (Q4 2025), and $67.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 816.00 Mn |
| 10 | Xeris Biopharma Holdings | 1.48 Bn | 1.36 Bn | 79.59 Mn | 80.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 80.93 Mn |
| Mar 31, 2026 | 74.23 Mn |
| Dec 31, 2025 | 68.67 Mn |
| Sep 30, 2025 | 67.46 Mn |
| Jun 30, 2025 | 67.28 Mn |
| Mar 31, 2025 | 52.69 Mn |
| Dec 31, 2024 | 48.18 Mn |
| Sep 30, 2024 | 45.12 Mn |
| Jun 30, 2024 | 42.98 Mn |
| Mar 31, 2024 | 40.88 Mn |
| Dec 31, 2023 | 38.84 Mn |
| Sep 30, 2023 | 38.14 Mn |
| Jun 30, 2023 | 36.54 Mn |
| Mar 31, 2023 | 29.04 Mn |
| Dec 31, 2022 | 24.74 Mn |
| Sep 30, 2022 | 20.12 Mn |
| Jun 30, 2022 | 17.89 Mn |
| Mar 31, 2022 | 16.87 Mn |
| Dec 31, 2021 | 18.12 Mn |
| Sep 30, 2021 | 14.24 Mn |